BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28629664)

  • 1. Essential elements of personalized medicine.
    Burke W; Brown Trinidad S; Press NA
    Urol Oncol; 2014 Feb; 32(2):193-7. PubMed ID: 24321254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing Prostate Cancer Care: Treatment Approaches to Precision Medicine, Biomarker Innovations, and Equitable Access.
    Fenton SE; VanderWeeler DJ; Rebbeck TR; Chen DL
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e433138. PubMed ID: 38781539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.
    Fayanju OM; Park KU; Lucci A
    Ann Surg Oncol; 2018 Feb; 25(2):512-519. PubMed ID: 29159748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic biomarkers to guide precision radiotherapy in prostate cancer.
    Sutera P; Deek MP; Van der Eecken K; Wyatt AW; Kishan AU; Molitoris JK; Ferris MJ; Siddiqui MM; Rana Z; Mishra MV; Kwok Y; Davicioni E; Spratt DE; Ost P; Feng FY; Tran PT
    Prostate; 2022 Aug; 82 Suppl 1(Suppl 1):S73-S85. PubMed ID: 35657158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of circRNAs in serum of patients undergoing prostate biopsy.
    Samirae L; Krausewitz P; Alajati A; Kristiansen G; Ritter M; Ellinger J
    Int J Urol; 2024 May; 31(5):578-580. PubMed ID: 38363018
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification and evaluation of clinically significant prostate cancer: a step towards personalized diagnosis.
    Ali A; Hoyle A; Baena E; Clarke NW
    Curr Opin Urol; 2017 May; 27(3):217-224. PubMed ID: 28212121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relevance of circRNAs in serum of patients undergoing prostate biopsy.
    Urabe F
    Int J Urol; 2024 May; 31(5):581. PubMed ID: 38469670
    [No Abstract]   [Full Text] [Related]  

  • 8. PAM50 and Beyond: When Will Tissue Transcriptomics Guide Clinical Decision-making?
    Haywood SC; Gupta S; Heemers HV
    Eur Urol Focus; 2022 Jul; 8(4):916-918. PubMed ID: 36031559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular subtypes provide possibilities for precision medicine in a advanced prostate cancer].
    Wikström P; Bergh A; Josefsson A; Thysell E; Welén K
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38656744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic Testing.
    Tsalatsanis A; Hozo I; Kumar A; Djulbegovic B
    PLoS One; 2015; 10(8):e0134800. PubMed ID: 26244571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision Treatments in Epilepsy.
    Demarest S; Brooks-Kayal A
    Neurotherapeutics; 2021 Jul; 18(3):1429-1431. PubMed ID: 34704188
    [No Abstract]   [Full Text] [Related]  

  • 12. How glycomic studies can impact on prostate cancer.
    Tkac J; Bertok T
    Expert Rev Proteomics; 2023; 20(10):189-191. PubMed ID: 37767873
    [No Abstract]   [Full Text] [Related]  

  • 13. Forget lung, breast or prostate cancer: why tumour naming needs to change.
    André F; Rassy E; Marabelle A; Michiels S; Besse B
    Nature; 2024 Feb; 626(7997):26-29. PubMed ID: 38347121
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic biomarkers of cancer risk.
    Calzone KA
    Semin Oncol Nurs; 2012 May; 28(2):122-8. PubMed ID: 22542320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guide to presenting clinical prediction models for use in clinical settings.
    Bonnett LJ; Snell KIE; Collins GS; Riley RD
    BMJ; 2019 Apr; 365():l737. PubMed ID: 30995987
    [No Abstract]   [Full Text] [Related]  

  • 16. The DETECT Trial: Are We on the Verge of Precision Surgery in Primary Prostate Cancer?
    Maurer T; Thomas C; Hadaschik B
    J Nucl Med; 2024 Mar; 65(3):430-431. PubMed ID: 38360053
    [No Abstract]   [Full Text] [Related]  

  • 17. Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: Yes.
    Palapattu GS
    J Urol; 2017 Aug; 198(2):265-266. PubMed ID: 28629664
    [No Abstract]   [Full Text] [Related]  

  • 18. Genomic Tests Should be Used to Help Guide Treatment of Prostate Cancer: No.
    Punnen S; Parekh DJ
    J Urol; 2017 Aug; 198(2):266-267. PubMed ID: 28629663
    [No Abstract]   [Full Text] [Related]  

  • 19. Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management.
    Nguyen JK; Magi-Galluzzi C
    Adv Anat Pathol; 2018 Sep; 25(5):293-303. PubMed ID: 29727322
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.